Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Sipos

Showing results (31-40 of 61) with videos related to

Pageof 7
Sort By:
International Journal of Colorectal Disease|September 1, 2005
Significant growth inhibition of orthotopic pancreatic ductal adenocarcinoma by CpG oligonucleotides in immunodeficient miceJ Tepel, O Dagvadorj, M Kapischke, et al.
Zeitschrift Fur Gastroenterologie|February 15, 2014
FOLFIRINOX as first-line treatment for unresectable acinar cell carcinoma of the pancreas: a case reportU Schempf, B Sipos, C König, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|February 9, 2012
Limited disease of extra-pulmonary small cell carcinoma. Impact of local treatment and nodal status, role of cranial irradiationA C Müller, C Gani, M Weinmann, et al.
British Journal of Cancer|July 11, 2013
Dipeptidase 1 (DPEP1) is a marker for the transition from low-grade to high-grade intraepithelial neoplasia and an adverse prognostic factor in colorectal cancerP A Eisenach, E Soeth, C Röder, et al.
Oncogene|February 14, 2007
Dissecting the role of TGF-beta type I receptor/ALK5 in pancreatic ductal adenocarcinoma: Smad activation is crucial for both the tumor suppressive and prometastatic functionB Schniewind, S Groth, S Sebens Müerköster, et al.
Carcinogenesis|January 18, 2007
WNT5A--target of CUTL1 and potent modulator of tumor cell migration and invasion in pancreatic cancerS Ripka, A König, M Buchholz, et al.
Virchows Archiv : an International Journal of Pathology|December 11, 1999
Duct changes and K-ras mutations in the disease-free pancreas: analysis of type, age relation and spatial distributionJ Lüttges, A Reinecke-Lüthge, B Möllmann, et al.
Mucosal Immunology|December 17, 2008
Psoriasin (S100A7) is a principal antimicrobial peptide of the human tongueJ E Meyer, J Harder, B Sipos, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|February 3, 2000
World Health organization (WHO) and the World Heart Federation (WHF) pathobiological determinants of atherosclerosis in youth study (WHO/WHF PBDAY Study) 1986-1996. Histomorphometry and histochemistry of atherosclerotic lesions in coronary arteries and the aorta in a young populationA Kádár, G Mózes, G Illyés, et al.
Oncogene|January 24, 2007
MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinomaA E Szafranska, T S Davison, J John, et al.
Pageof 7

Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
International Journal of Colorectal Disease|September 1, 2005
Significant growth inhibition of orthotopic pancreatic ductal adenocarcinoma by CpG oligonucleotides in immunodeficient miceJ Tepel, O Dagvadorj, M Kapischke, et al.
Zeitschrift Fur Gastroenterologie|February 15, 2014
FOLFIRINOX as first-line treatment for unresectable acinar cell carcinoma of the pancreas: a case reportU Schempf, B Sipos, C König, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|February 9, 2012
Limited disease of extra-pulmonary small cell carcinoma. Impact of local treatment and nodal status, role of cranial irradiationA C Müller, C Gani, M Weinmann, et al.
British Journal of Cancer|July 11, 2013
Dipeptidase 1 (DPEP1) is a marker for the transition from low-grade to high-grade intraepithelial neoplasia and an adverse prognostic factor in colorectal cancerP A Eisenach, E Soeth, C Röder, et al.
Oncogene|February 14, 2007
Dissecting the role of TGF-beta type I receptor/ALK5 in pancreatic ductal adenocarcinoma: Smad activation is crucial for both the tumor suppressive and prometastatic functionB Schniewind, S Groth, S Sebens Müerköster, et al.
Carcinogenesis|January 18, 2007
WNT5A--target of CUTL1 and potent modulator of tumor cell migration and invasion in pancreatic cancerS Ripka, A König, M Buchholz, et al.
Virchows Archiv : an International Journal of Pathology|December 11, 1999
Duct changes and K-ras mutations in the disease-free pancreas: analysis of type, age relation and spatial distributionJ Lüttges, A Reinecke-Lüthge, B Möllmann, et al.
Mucosal Immunology|December 17, 2008
Psoriasin (S100A7) is a principal antimicrobial peptide of the human tongueJ E Meyer, J Harder, B Sipos, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|February 3, 2000
World Health organization (WHO) and the World Heart Federation (WHF) pathobiological determinants of atherosclerosis in youth study (WHO/WHF PBDAY Study) 1986-1996. Histomorphometry and histochemistry of atherosclerotic lesions in coronary arteries and the aorta in a young populationA Kádár, G Mózes, G Illyés, et al.
Oncogene|January 24, 2007
MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinomaA E Szafranska, T S Davison, J John, et al.
Pageof 7